Cat:GMP-MPV-Tg04-nAb
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-MPV-Tg04-nAb Categories ,

Description

Cat No.

GMP-MPV-Tg04-nAb001

Target

A25

Product Name (Neutralizing antibody Name)

Anti-MPV (A25) human monoclonal neutralizing antibody (IgG1)

Source (Expression Host)

Mammalian (human cell)

Isotypes

human IgG1

Bioactivity validation

Validated in Monkeypox virus (MPV) A25 antigen protein binding affnity.ELISA validated as capture antibody and detection antibody. Pair recommendation with other A25 antibodies in A25 level test of Monkeypox virus (MPV) infectious diseases.

Tag

hFc

Products description

Anti-MPV (A25) human monoclonal neutralizing antibody (IgG1) is a potency validated Monkeypox virus (MPV) neutralizing antibody. It is a human IgG1 antibody produced by Mammalian (human cell). The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other A25 antibodies.

Reconized/Reactive Species

Human

Purity

Purity: ≥95% (SDS-PAGE)

Application

This antibodies can either act as positive control in Monkeypox virus (MPV) related vaccines and neutralizing antibodies discovery and development, or act as a benchmark in Monkeypox virus (MPV) neutralization potency assay. ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.